Some patients are now searching to find pharmacies that can fill their prescription, or going without.
The weekly semaglutide or tirzepatide injectables for diabetes and weight loss are often hailed by patients for the major difference they can make.
Since the drugs are still so new, we don’t have much long-term research yet what that impact could be. But doctors do know when patients suddenly stop or try to restart higher doses after a break, it can cause even more struggles. “It's not like you can stop your therapeutic dose, and then go back to it a week or two later. The dire consequences are increased side effects, GI upsets like nausea and vomiting, diarrhea, constipation that can actually increase if this is stopped abruptly,” said Dr. Chae.Ozempic maker sets clinical trial to study drug's effect on alcohol consumption Alex Arger 4:39 PM, May 20, 2024 Blood sugar spikes and intense carb cravings can come too, he says.
Chae says some patients could discuss with their doctor off-label use of other medications, like liraglutide injections , depending on their preexisting conditions.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
New Research Links Popular Hormone Drugs to Brain TumorsScience, Space and Technology News 2024
Read more »
TikTok scam promises popular weight loss drugs without a prescriptionA joint investigation by Digital Citizens Alliance and Coalition for a Safer Web found dozens of TikTok profiles offering to ship weight loss drugs for lower prices and without a prescription. In nearly every situation, it was a scam.
Read more »
Eli Lilly beefs up plan to expand manufacturing for popular drugs Zepbound, MounjaroEli Lilly will spend more than $5 billion to expand an Indiana manufacturing site and eventually make more doses of its hot-selling weight-loss and diabetes treatments, Zepbound and Mounjaro. The drugmaker said Friday that it was more than doubling its investment in a site near its Indianapolis headquarters.
Read more »
Eli Lilly beefs up plan to expand manufacturing for popular drugs Zepbound, MounjaroEli Lilly will spend more than $5 billion to expand an Indiana manufacturing site and eventually make more doses of its hot-selling weight-loss and diabetes treatments, Zepbound and Mounjaro.
Read more »
Eli Lilly beefs up plan to expand manufacturing for popular drugs Zepbound, MounjaroEli Lilly will spend more than $5 billion to expand an Indiana manufacturing site and eventually make more doses of its hot-selling weight-loss and diabetes treatments, Zepbound and Mounjaro.
Read more »
– Young Adults’ Use of Popular Weight Loss Drugs Wegovy and Ozempic Skyrockets by 594%Science, Space and Technology News 2024
Read more »